Your browser doesn't support javascript.
loading
AIDS-related sinonasal Burkitt lymphoma successfully treated with intensive chemotherapy regimen and high active antiretroviral therapy
Hematology, Oncology and Stem Cell Therapy. 2011; 4 (1): 41-44
em Inglês | IMEMR | ID: emr-110146
ABSTRACT
Burkitt lymphoma [BL] is the second most common AIDS-related lymphoma. Primary sinonasal BL in HIV patients is extremely rare and treatment data in this subset of patients is almost nonexistent. Recently, a few studies reported promising results treating HIV-associate BL with an intensive chemotherapy regimen. The use of highly active antiretroviral therapy [HAART] concomitantly with chemotherapy seems to improve patient outcomes, but this topic is still controversial due to potential drug interactions. We report a case of a 29-year old woman diagnosed with AIDS presenting with symptoms of chronic sinusitis. Subsequent investigation by CT scan and endoscopic biopsy discovered a sinonasal BL in an early stage. The patient was treated with intensive chemotherapy and HAART and achieved a complete remission and long-term immunologic recovery. This case report describes a rare entity whose natural history, treatment and prognosis is infrequently characterized in the medical literature
Assuntos
Buscar no Google
Índice: IMEMR (Mediterrâneo Oriental) Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Taxa de Sobrevida / Resultado do Tratamento / Linfoma Relacionado a AIDS / Terapia Antirretroviral de Alta Atividade Tipo de estudo: Relato de Casos Limite: Feminino / Humanos Idioma: Inglês Revista: Hematol. Oncol. Stem Cell Ther. Ano de publicação: 2011

Similares

MEDLINE

...
LILACS

LIS

Buscar no Google
Índice: IMEMR (Mediterrâneo Oriental) Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Taxa de Sobrevida / Resultado do Tratamento / Linfoma Relacionado a AIDS / Terapia Antirretroviral de Alta Atividade Tipo de estudo: Relato de Casos Limite: Feminino / Humanos Idioma: Inglês Revista: Hematol. Oncol. Stem Cell Ther. Ano de publicação: 2011